Hilltop Holdings’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$421K Sell
5,334
-755
-12% -$64.2K 0.03% 467
2026
Q1
$525K Sell
6,089
-28
-0.5% -$2.51K 0.05% 381
2025
Q4
$534K Sell
6,117
-1,040
-15% -$78.9K 0.03% 523
2025
Q3
$410K Sell
7,157
-92
-1% -$5.3K 0.02% 631
2025
Q2
$428K Buy
7,249
+873
+14% +$56.4K 0.03% 573
2025
Q1
$467K Buy
+6,376
New +$527K 0.03% 534

Other funds holding GMED

Hilltop Holdings's GMED Position: Q2 2026 in Review

Hilltop Holdings reduced its Globus Medical (GMED) stake by 12% in Q2 2026, selling an estimated $64.2K and leaving 5,334 shares worth $421K. The position accounts for 0.03% of the portfolio, ranked #467.

Hilltop Holdings first reported a position in GMED in Q1 2025 and has held it in 6 quarters since. The position peaked at $534K in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Hilltop Holdings held 5,334 shares of Globus Medical worth $421K as of Q2 2026.
  • Hilltop Holdings sold 755 Globus Medical shares in Q2 2026, an estimated $64.2K.
  • Globus Medical made up 0.03% of Hilltop Holdings's portfolio in Q2 2026, its #467 holding.
  • Hilltop Holdings first reported a position in Globus Medical in Q1 2025 and has held it in 6 quarters since.
  • Hilltop Holdings's Globus Medical position peaked at $534K in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Hilltop Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.